Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Follow up Monitoring Between Cycles (Part 3)

This is the last episode of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab Soravtansine. The multidisciplinary panel discusses the challenges with patient monitoring while on Mirvetuximab soravtansine. The panel discusses personal clinical experiences and lessons learned.  When to dose adjust and hold or even discontinue Mirvetuximab soravtansine. Once again, the session ends with take home points for patient monitoring while on Mirvetuximab soravtansine.  

Speaker(s)/Moderator(s):
2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators
Tracilyn Hall, MD
Judith A. Smith, B.S., Pharm.D, BCOP, CPHQ
    Speakers:
    Julia Canestraro, OD, FAAO
    Karen Lyle, PA-C
    Kathleen Moore, MD
     
    Keywords: Mirvetuximab soravtansine; administration of Mirvetuximab soravtansine; keeping up with the chemos series, drug administration; eye drop prescriptions; home medications; and patient education; dose adjust; toxicity prevention interventions
     
    This podcast was recorded in February 2023.

    Target Audience

    SGO Members

    You may also be interested in

    Keeping up with the Chemos Series: Lenvatinib/Pembrolizumab - Preparing to Give It (Part 1)
    The first three-part of the Keeping up with the Chemos podcast series focused on tisotumab vedotin. Now, this second installment series focuses on lenvatinib/pembrolizumab.
    Keeping up with the Chemos Series: Tisotumab Vedotin - Preparing to Give It (Part 1)

    This is the first of the three-part podcast series, Keeping up with the Chemos, on tisotumab vedotin.
    Course summary
    Course opens: 
    04/11/2023
    Course expires: 
    04/11/2033
    Cost:
    $0.00
    Rating: 
    0

    Price

    Cost:
    $0.00
    Please login or register to take this course.